REVENUE (Tables)

9 Months Ended

Sep. 30, 2021

REVENUE [Abstract]

Disaggregation of Revenue

The following table disaggregates total revenues:

	For the three months ended
	September 30, 2021						September 30, 2020
	Exchange Transactions		Non-Exchange Transactions		Total		Exchange Transactions		Non-Exchange Transactions		Total
Net product sales	$	9,371,160	$	-	$	9,371,160	$	8,406,457	$	-	$	8,406,457
R&D revenue		441		-		441		1,444,724		-		1,444,724
Government grant income		-		2,400,000		2,400,000		-		209,776		209,776
License and royalty revenue		286,843		-		286,843		211,521		-		211,521
	$	9,658,444	$	2,400,000	$	12,058,444	$	10,062,702	$	209,776	$	10,272,478

	For the nine months ended
	September 30, 2021						September 30, 2020
	Exchange Transactions		Non-Exchange Transactions		Total		Exchange Transactions		Non-Exchange Transactions		Total
Net product sales	$	17,327,204	$	-	$	17,327,204	$	17,914,623	$	-	$	17,914,623
R&D revenue		1,107,808		-		1,107,808		3,546,385		-		3,546,385
Government grant income		-		8,030,000		8,030,000		-		209,776		209,776
License and royalty revenue		779,901		-		779,901		572,450		-		572,450
	$	19,214,913	$	8,030,000	$	27,244,913	$	22,033,458	$	209,776	$	22,243,234

The following table disaggregates total revenues by geographic location:

	For the three months ended				For the nine months ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Africa	$	1,293,405	$	1,874,518	$	4,104,619	$	3,310,603
Asia		208,750		168,052		479,297		650,659
Europe & Middle East		1,132,961		2,887,209		4,539,444		6,698,382
Latin America		5,698,920		4,618,560		6,444,456		7,515,523
United States		3,724,408		724,139		11,677,097		4,068,067
	$	12,058,444	$	10,272,478	$	27,244,913	$	22,243,234